Telotristat etiprate
Term · Oncology and biomedicine · MLC-T-ONC-017057
An orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor prodrug, with potential antiserotonergic activity. Upon administration, telotristat etiprate is converted to its active moiety, telotristat (LP-778902), which binds to and blocks the activity of TPH. This may result in a reduction in peripheral serotonin (5-HT) production and improvement of serotonin-mediated gastrointestinal effects such as severe diarrhea. TPH, the rate-limiting enzyme in serotonin biosynthesis, is overexpressed in carcinoid tumor cells.
| Identifier | MLC-T-ONC-017057 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | telotristat ethyl; tryptophan hydroxylase inhibitor LX1032; TPH inhibitor LX1606; TPHI inhibitor LX1032 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017057",
"term": "Telotristat etiprate",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor prodrug, with potential antiserotonergic activity. Upon administration, telotristat etiprate is converted to its active moiety, telotristat (LP-778902), which binds to and blocks the activity of TPH. This may result in a reduction in peripheral serotonin (5-HT) production and improvement of serotonin-mediated gastrointestinal effects such as severe diarrhea. TPH, the rate-limiting enzyme in serotonin biosynthesis, is overexpressed in carcinoid tumor cells.",
"synonyms": [
"telotristat ethyl",
"tryptophan hydroxylase inhibitor LX1032",
"TPH inhibitor LX1606",
"TPHI inhibitor LX1032"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/telotristat-etiprate/"
}
Record 16,125 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.